Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $10,428 - $15,739
-95 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$59.04 - $88.81 $2,361 - $3,552
-40 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $2,379 - $3,311
40 New
40 $3,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Nwk Group, Inc. Portfolio

Follow Nwk Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nwk Group, Inc. with notifications on news.